Concepedia

Mengxian Zhang

MZ

Statistics

Publications

9

Citations

337

H-Index

9

Active since

2011

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

German Cancer Research Center

Eli Lilly (United States)

University Hospital Heidelberg

Mengxian Zhang is an author at Huazhong University of Science and Technology specializing in oncology, medicine, and molecular oncology.

Publications per year

2011–2023

9

Publications

9

Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761

Mengxian Zhang, Tobias W. Herion, Carmen Timke et al. · Neoplasia · 2011 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value

Yangmei Zhou, Yang Li, Xiaoxi Zhang et al. · BioMed Research International · 2019 · 77 citations · Full text

Medicine, Bioinformatics, Oncology +17

Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors

Lingcheng Zeng, Yan Wang, Yu Wang et al. · Journal of Neuro-Oncology · 2016 · 36 citations

Medicine, Oncology, Pathology +6

<i>Notch1</i>ablation radiosensitizes glioblastoma cells

Na Han, G. Hu, Lei Shi et al. · Oncotarget · 2017 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma

Qiuyun Guo, Na Han, Lei Shi et al. · Oncology Reports · 2019 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 9